Commonwealth Equity Services’s Medicus Pharma MDCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.5K Buy
52,643
+4,500
+9% +$1.59K ﹤0.01% 4352
2026
Q1
$22.1K Buy
48,143
+19,650
+69% +$20.5K ﹤0.01% 4249
2025
Q4
$43.6K Buy
28,493
+17,611
+162% +$37.7K ﹤0.01% 4195
2025
Q3
$25K Buy
+10,882
New +$27.3K ﹤0.01% 4200

Other funds holding MDCX

Commonwealth Equity Services's MDCX Position: Q2 2026 in Review

Commonwealth Equity Services increased its Medicus Pharma (MDCX) stake by 9.3% in Q2 2026, buying an estimated $1.59K and bringing the position to 52,643 shares worth $23.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4352.

Commonwealth Equity Services first reported a position in MDCX in Q3 2025 and has held it in 4 quarters since. The position peaked at $43.6K in Q4 2025. 5 funds tracked by Wall St. Rank hold MDCX as of Q2 2026.

  • Commonwealth Equity Services held 52,643 shares of Medicus Pharma worth $23.5K as of Q2 2026.
  • Commonwealth Equity Services bought 4,500 Medicus Pharma shares in Q2 2026, an estimated $1.59K.
  • Medicus Pharma made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #4352 holding.
  • Commonwealth Equity Services first reported a position in Medicus Pharma in Q3 2025 and has held it in 4 quarters since.
  • Commonwealth Equity Services's Medicus Pharma position peaked at $43.6K in Q4 2025.
  • 5 funds tracked by Wall St. Rank held Medicus Pharma as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.